Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer’s disease and other neurodegenerative diseases
出版年份 2017 全文链接
标题
Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer’s disease and other neurodegenerative diseases
作者
关键词
-
出版物
Expert Review of Proteomics
Volume 14, Issue 4, Pages 285-299
出版商
Informa UK Limited
发表日期
2017-03-11
DOI
10.1080/14789450.2017.1304217
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Chitinase 3-like 1 is associated with the response to interferon-beta treatment in multiple sclerosis
- (2017) Clara Matute-Blanch et al. JOURNAL OF NEUROIMMUNOLOGY
- Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
- (2016) Bruno Dubois et al. Alzheimers & Dementia
- Neuroinflammation in Alzheimer's disease: Current evidence and future directions
- (2016) Valeria Calsolaro et al. Alzheimers & Dementia
- Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease
- (2016) Simone Lista et al. Expert Review of Neurotherapeutics
- Cerebrospinal Fluid Markers of Alzheimer’s Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer’s Disease
- (2016) Kelsey E. Melah et al. JOURNAL OF ALZHEIMERS DISEASE
- Targeting innate immunity for neurodegenerative disorders of the central nervous system
- (2016) Katrin I. Andreasson et al. JOURNAL OF NEUROCHEMISTRY
- YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis
- (2016) Joachim Burman et al. JOURNAL OF NEUROIMMUNOLOGY
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
- (2016) Sara Hall et al. MOVEMENT DISORDERS
- CSF YKL-40 and pTau181 are related to different cerebral morphometric patterns in early AD
- (2016) Juan Domingo Gispert et al. NEUROBIOLOGY OF AGING
- How neuroinflammation contributes to neurodegeneration
- (2016) R. M. Ransohoff SCIENCE
- Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease
- (2016) Simone Lista et al. Expert Review of Neurotherapeutics
- Biomarker-guided classification scheme of neurodegenerative diseases
- (2016) Filippo Baldacci et al. Journal of Sport and Health Science
- Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington’s Disease
- (2016) Filipe Brogueira Rodrigues et al. PLoS One
- Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions
- (2015) James Varley et al. Alzheimers & Dementia
- Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes
- (2015) Ester Cantó et al. BRAIN
- The genetic landscape of Alzheimer disease: clinical implications and perspectives
- (2015) Caroline Van Cauwenberghe et al. GENETICS IN MEDICINE
- The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease
- (2015) Myles R. Minter et al. JOURNAL OF NEUROCHEMISTRY
- Mapping neuroinflammation in frontotemporal dementia with molecular PET imaging
- (2015) Jing Zhang Journal of Neuroinflammation
- Dissecting IWG-2 typical and atypical Alzheimer’s disease: insights from cerebrospinal fluid analysis
- (2015) Ross W. Paterson et al. JOURNAL OF NEUROLOGY
- A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes
- (2015) N K Magdalinou et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis
- (2015) G Hinsinger et al. Multiple Sclerosis Journal
- Immune attack: the role of inflammation in Alzheimer disease
- (2015) Frank L. Heppner et al. NATURE REVIEWS NEUROSCIENCE
- Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease
- (2015) Daniel Alcolea et al. NEUROBIOLOGY OF AGING
- Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
- (2015) Daniel Alcolea et al. NEUROLOGY
- The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but Not Parkinson’s Disease or Dementia with Lewy Bodies
- (2015) Malin Wennström et al. PLoS One
- Elevated Plasma YKL-40, Lipids and Lipoproteins, and Ischemic Vascular Disease in the General Population
- (2015) Alisa D. Kjaergaard et al. STROKE
- The choreography of neuroinflammation in Huntington's disease
- (2015) Andrea Crotti et al. TRENDS IN IMMUNOLOGY
- Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer’s disease in a memory clinic cohort
- (2015) Maartje I. Kester et al. Alzheimers Research & Therapy
- Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
- (2015) Konstantin Hellwig et al. Alzheimers Research & Therapy
- Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
- (2015) Courtney L. Sutphen et al. JAMA Neurology
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis
- (2015) G Hinsinger et al. Multiple Sclerosis Journal
- Microglial dysfunction in brain aging and Alzheimer's disease
- (2014) Kira Irving Mosher et al. BIOCHEMICAL PHARMACOLOGY
- Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
- (2014) Christiane Reitz et al. BIOCHEMICAL PHARMACOLOGY
- CSF levels of YKL-40 are increased in MS and decrease with immunosuppressive treatment
- (2014) Clas Malmeström et al. JOURNAL OF NEUROIMMUNOLOGY
- Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions
- (2014) Nadia Magdalinou et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
- (2014) Kristin R Wildsmith et al. Molecular Neurodegeneration
- YKL-40 in cerebrospinal fluid in Huntington's disease – A role in pathology or a nonspecific response to inflammation?
- (2014) Tua Vinther-Jensen et al. PARKINSONISM & RELATED DISORDERS
- Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study
- (2014) Martina Giuntini et al. PARKINSONISM & RELATED DISORDERS
- Diverse pathological implications of YKL-40: Answers may lie in ‘outside-in’ signaling
- (2013) Mansi Prakash et al. CELLULAR SIGNALLING
- Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease
- (2013) Michelle A Erickson et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease
- (2013) Sruti Rayaprolu et al. Molecular Neurodegeneration
- The glial marker YKL-40 is decreased in synucleinopathies
- (2013) Bob Olsson et al. MOVEMENT DISORDERS
- α-Synucleinopathy phenotypes
- (2013) Heather McCann et al. PARKINSONISM & RELATED DISORDERS
- Molecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis
- (2013) Philippe Corcia et al. PLoS One
- Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration
- (2013) V. Hugh Perry et al. Seminars in Immunopathology
- Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
- (2013) T. Wyss-Coray et al. Cold Spring Harbor Perspectives in Medicine
- Development of biomarkers to chart all Alzheimer’s disease stages: The royal road to cutting the therapeutic Gordian Knot
- (2012) Harald Hampel et al. Alzheimers & Dementia
- National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
- (2012) Bradley T. Hyman et al. Alzheimers & Dementia
- Meta-analysis of early nonmotor features and risk factors for Parkinson disease
- (2012) Alastair J. Noyce et al. ANNALS OF NEUROLOGY
- Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension
- (2012) Wei-hong Ma et al. BMC Cardiovascular Disorders
- YKL-40 levels and atrial fibrillation in the general population
- (2012) Sarah C.W. Marott et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Genetic insights in Alzheimer's disease
- (2012) Karolien Bettens et al. LANCET NEUROLOGY
- Translational biomarker discovery in clinical metabolomics: an introductory tutorial
- (2012) Jianguo Xia et al. Metabolomics
- Variations of CHI3L1, Levels of the Encoded Glycoprotein YKL-40 and Prediction of Fatal and Non-fatal Ischemic Stroke
- (2012) Camilla Noelle Rathcke et al. PLoS One
- Serum YKL-40 Levels Correlate with Infarct Volume, Stroke Severity, and Functional Outcome in Acute Ischemic Stroke Patients
- (2012) Hyun Young Park et al. PLoS One
- SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy
- (2012) Leah Winer et al. JAMA Neurology
- Extended results of the Alzheimer’s disease anti-inflammatory prevention trial
- (2011) John C. Breitner et al. Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury
- (2011) Chun Geun Lee et al. Annual Review of Physiology
- Astrocyte and Macrophage Regulation of YKL-40 Expression and Cellular Response in Neuroinflammation
- (2011) Dafna Bonneh-Barkay et al. BRAIN PATHOLOGY
- Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease
- (2011) Chuanyu Li et al. Current Alzheimer Research
- Diabetes and Risk of Parkinson's Disease: A systematic review and meta-analysis
- (2011) E. Cereda et al. DIABETES CARE
- Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease
- (2011) Paula Grammas Journal of Neuroinflammation
- Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer’s disease
- (2011) Jihye Choi et al. JOURNAL OF NEUROLOGY
- The projected effect of risk factor reduction on Alzheimer's disease prevalence
- (2011) Deborah E Barnes et al. LANCET NEUROLOGY
- Complement in the brain
- (2011) Robert Veerhuis et al. MOLECULAR IMMUNOLOGY
- Caspase signalling controls microglia activation and neurotoxicity
- (2011) Miguel A. Burguillos et al. NATURE
- Clinical diagnosis of Alzheimer's disease: Report of the NINCDS--ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
- (2011) G. McKhann et al. NEUROLOGY
- Cerebrospinal Fluid Microglial Markers in Alzheimer’s Disease: Elevated Chitotriosidase Activity but Lack of Diagnostic Utility
- (2011) Niklas Mattsson et al. NEUROMOLECULAR MEDICINE
- Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease
- (2011) Richard J. Perrin et al. PLoS One
- The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
- (2010) Costantino Iadecola ACTA NEUROPATHOLOGICA
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
- (2010) Rebecca Craig-Schapiro et al. BIOLOGICAL PSYCHIATRY
- Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis
- (2010) Manuel Comabella et al. BRAIN
- Mechanisms Underlying Inflammation in Neurodegeneration
- (2010) Christopher K. Glass et al. CELL
- Report of the ad Hoc committee on nomenclature and standards for bone proteins and growth factors
- (2010) Peter V. Hauschka et al. JOURNAL OF BONE AND MINERAL RESEARCH
- In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases
- (2010) Dafna Bonneh-Barkay et al. Journal of Neuroinflammation
- YKL-40 Expression in Traumatic Brain Injury: An Initial Analysis
- (2010) Dafna Bonneh-Barkay et al. JOURNAL OF NEUROTRAUMA
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
- Differentiating vascular parkinsonism from idiopathic Parkinson's disease: A systematic review
- (2010) Seema Kalra et al. MOVEMENT DISORDERS
- Microglial activation in healthy aging
- (2010) Alie Schuitemaker et al. NEUROBIOLOGY OF AGING
- Carbon 11–Labeled Pittsburgh Compound B and Carbon 11–Labeled (R)-PK11195 Positron Emission Tomographic Imaging in Alzheimer Disease
- (2009) Clayton A. Wiley et al. ARCHIVES OF NEUROLOGY
- YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
- (2009) Camilla N Rathcke et al. Cardiovascular Diabetology
- Plasma YKL-40, a new biomarker for atrial fibrillation?
- (2009) K. M. Henningsen et al. EUROPACE
- The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal
- (2009) John Hardy JOURNAL OF NEUROCHEMISTRY
- Microglial activation and amyloid deposition in mild cognitive impairment: A PET study
- (2009) A. Okello et al. NEUROLOGY
- Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT)
- (2008) ARCHIVES OF NEUROLOGY
- Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study
- (2008) Paul Edison et al. NEUROBIOLOGY OF DISEASE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started